MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin

Osteosarcoma (OS) is the most common primary pediatric malignancy of the bone having poor prognosis and long-term survival rates of less than 30% in patients with metastasis. MicroRNA-509 was reported to be downregulated in OS. We and others previously published that miR-509-3p can strongly attenuat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Patil, Sagar L., Palat, Asha, Pan, Yinghong, Rajapakshe, Kimal, Mirchandani, Rachna, Bondesson, Maria, Yustein, Jason T., Coarfa, Cristian, Gunaratne, Preethi H.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6911094/
https://ncbi.nlm.nih.gov/pubmed/31836741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-55170-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky